The mRNA synthesis and manufacturing market's potential lies in the increasing demand for mRNA therapeutics and vaccines, driven by COVID-19 successes. Opportunities include mRNA custom synthesis and ...
Researchers at St. Jude built a machine learning model to predict which protein regions drive cancer-linked condensates.
AZoLifeSciences on MSN
Syntax Bio develops CRISPR technology to program stem cell gene activity
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Zwerling expected to guide the Company to its commercial launchAPOLLO BEACH, Fla., Dec. 08, 2025 (GLOBE NEWSWIRE) -- ...
The affordable cost of living, proximity to Australia’s third-largest capital city are just a few of the reasons Riviera ...
We came across a bullish thesis on Wave Life Sciences Ltd. on Valueinvestorsclub.com by zamperini. In this article, we will ...
Investing.com -- Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) stock surged 14.7% Monday after the company announced it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-MAPT, its ...
Arrowhead Pharmaceuticals, Inc. today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-MAPT, the company's investigational RNA interference (RNAi) therapeutic being ...
Renaissance BioScience’s novel RNA production and delivery technology receives Mexican patent: Vancouver, Canada Monday, December 8, 2025, 17:00 Hrs [IST] Renaissance BioScience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback